Elevance Health, Inc. Company Analysis & Research
Elevance Health has transformed from a regional Blue Cross Blue Shield insurer into a diversified health services behemoth. The company serves approximately 104 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. With $197.6 billion in 2025 revenue, Elevance is navigating significant regulatory and reimbursement headwinds in 2026.
ELV's unique strength is its exclusive license to the Blue Cross Blue Shield brand in 14 states, providing a 'moat' of brand recognition that competitors struggle to match in those territories. The company has successfully built the infrastructure of a modern health giant through Carelon, but it is currently being buffeted by a 'perfect storm' of rising medical costs and shrinking government reimbursements.
Company Overview
Founded: 1944. Headquarters: Indianapolis, Indiana. Revenue: $197.6B. Employees: null. Market Cap: $75.3B. Ticker: ELV (NYSE).
Industry
Health Insurance & Managed Care
Cyborg Score: 5/10 — Mixed
Operationally challenged near-term but positioned for recovery if management executes pricing discipline and cost management in 2026-2027.
The company faces significant headwinds from the 'One Big Beautiful Bill Act' mandating Medicaid cuts, while the Trump administration's focus on flat Medicare Advantage rates pressures the entire sector. However, strong Carelon growth and market position provide resilience amid transformation.
Key Strategic Insights for Elevance Health, Inc.
- FY 2025 Revenue: $197.6 billion, up 13% year-over-year.
- Carelon's revenue climbed 27% to $18.7 billion, demonstrating strong growth in the high-margin services segment.
- Medicaid operating margins expected at approximately negative 1.75% for 2026, reflecting the core profitability challenge.
- CEO Gail Boudreaux said Elevance anticipates returning to at least 12% adjusted EPS growth in 2027, signaling management confidence in recovery trajectory.
Recent Developments
- (January 2026) Elevance reported Q4 2025 results with $49.3B quarterly revenue and issued cautious 2026 guidance amid regulatory uncertainty.
- (January 2026) Stock experienced significant volatility following Medicare Advantage rate announcement (0.09% increase for 2027).
- (April 2025) Acquisition of Granular Insurance Company to expand service capabilities.
Competitors & Competitive Landscape
- UnitedHealth Group — Largest managed-care competitor with extensive MA portfolio
- Humana — Major competitor in Medicare Advantage and Medicaid
- CVS Health — Integrated healthcare and PBM competitor
- Elevance Health — Core health insurance brand and market leader
One of Elevance Health's 9 competitors is Humana, a Corporation company based in Louisville, KY. The managed-care sector faces intense pressure from medical cost inflation and shrinking government reimbursement rates. Elevance remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025, offering employer, individual, and government-sponsored coverage plans, and differs from peers through its position as the largest single provider of Blue Cross Blue Shield branded coverage.
More Company Research
Intchains Group Limited Braemar Hotels & Resorts Inc. Commerce.com, Inc. (formerly BigCommerce Holdings, Inc.) E7 Group PJSC Viridien MAAS Group Holdings Limited nLIGHT, Inc. Y.H. Dimri Construction & Development Ltd Fortune Brands Innovations, Inc. Galenica AG Bharti Hexacom Limited Amundi S.A. WuXi AppTec Co., Ltd. Khadi and Village Industries Commission (KVIC) SolarMax Technology, Inc.Full Company Research Reports
Looking for a more in-depth analysis of Elevance Health, Inc.? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, analyst debate audio, and saved-company audio playlists.